Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin Dong

Showing results (1061-1070 of 1,064) with videos related to

Pageof 107
Sort By:
You have reached the last page of results.This site can display upto 1,064 results.
Frontiers of Medicine|March 9, 2021
Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trialDongsheng Wang, Binqing Fu, Zhen Peng, et al.
Genome Medicine|February 25, 2022
DrABC: deep learning accurately predicts germline pathogenic mutation status in breast cancer patients based on phenotype dataJiaqi Liu, Hengqiang Zhao, Yu Zheng, et al.
Annals of Neurology|June 24, 2025
Clinical and Genetic Findings in a Chinese Cohort of Dentatorubral-Pallidoluysian Atrophy PatientsRu-Ying Yuan, Ya-Fang Chen, Wei Lin, et al.
Signal Transduction and Targeted Therapy|April 13, 2025
Meplazumab, a CD147 antibody, for severe COVID-19: a double-blind, randomized, placebo-controlled, phase 3 clinical trialHuijie Bian, Liang Chen, Zheng Zhang, et al.
Pageof 107

Showing results (1061-1070 of 1,064) with videos related to

Sort By:
Pageof 107
You have reached the last page of results.This site can display upto 1,064 results.
Frontiers of Medicine|March 9, 2021
Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trialDongsheng Wang, Binqing Fu, Zhen Peng, et al.
Genome Medicine|February 25, 2022
DrABC: deep learning accurately predicts germline pathogenic mutation status in breast cancer patients based on phenotype dataJiaqi Liu, Hengqiang Zhao, Yu Zheng, et al.
Annals of Neurology|June 24, 2025
Clinical and Genetic Findings in a Chinese Cohort of Dentatorubral-Pallidoluysian Atrophy PatientsRu-Ying Yuan, Ya-Fang Chen, Wei Lin, et al.
Signal Transduction and Targeted Therapy|April 13, 2025
Meplazumab, a CD147 antibody, for severe COVID-19: a double-blind, randomized, placebo-controlled, phase 3 clinical trialHuijie Bian, Liang Chen, Zheng Zhang, et al.
Pageof 107